Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NST-1024 in Severe Hypertriglyceridemia
NCT05889156Phase 2Completed
- Sponsor
- NorthSea Therapeutics
- Start
- Jun 2023
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of icosabutate in hypertriglyceridemia, sponsored by NorthSea Therapeutics. Started Jun 2023; status: completed.
02
Drugs
icosabutate
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT05889156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05889156.